These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
854 related articles for article (PubMed ID: 9162267)
1. Infiltration and lysis of tumour cell aggregates by adherent interleukin-2-activated natural killer cells is distinct from specific cytolysis. Johansson BR; Unger ML; Albertsson P; Casselbrant A; Nannmark U; Hokland M Nat Immun; 1996-1997; 15(2-3):87-97. PubMed ID: 9162267 [TBL] [Abstract][Full Text] [Related]
2. Ultrastructure of interactions between activated murine natural killer cells and melanoma cells in an extracellular matrix (Matrigel) environment. Johansson BR; Nannmark U Nat Immun; 1996-1997; 15(2-3):98-106. PubMed ID: 9162268 [TBL] [Abstract][Full Text] [Related]
3. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation. Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491 [TBL] [Abstract][Full Text] [Related]
4. Expression and function of LFA-1 on A-NK and T-LAK cells: role in tumor target killing and migration into tumor tissue. Donskov F; Basse PH; Hokland M Nat Immun; 1996-1997; 15(2-3):134-46. PubMed ID: 9162263 [TBL] [Abstract][Full Text] [Related]
5. Tumor blood supply and tumor localization by adoptively transferred IL-2 activated natural killer cells. Nannmark U; Hokland ME; Agger R; Christiansen M; Kjaergaard J; Goldfarb RH; Bagge U; Unger M; Johansson BR; Albertsson PA; Basse PH In Vivo; 2000; 14(5):651-8. PubMed ID: 11125549 [TBL] [Abstract][Full Text] [Related]
6. Cooperation between CD44 and LFA-1/CD11a adhesion receptors in lymphokine-activated killer cell cytotoxicity. Matsumoto G; Nghiem MP; Nozaki N; Schmits R; Penninger JM J Immunol; 1998 Jun; 160(12):5781-9. PubMed ID: 9637488 [TBL] [Abstract][Full Text] [Related]
7. Antitumor activities of subsets of human IL-2-activated natural killer cells in solid tissues. Vujanovic NL; Yasumura S; Hirabayashi H; Lin WC; Watkins S; Herberman RB; Whiteside TL J Immunol; 1995 Jan; 154(1):281-9. PubMed ID: 7995947 [TBL] [Abstract][Full Text] [Related]
8. A novel drug delivery system using IL-2 activated NK cells and Zyn-linked doxorubicin. Goldfarb RH; Koelemij R; Muirhead KA; Ohlsson-Wilhelm BM; Gray BD; Kuppen PJ; Basse PH; al-Atrash G; Kitson RP In Vivo; 2000; 14(1):101-4. PubMed ID: 10757065 [TBL] [Abstract][Full Text] [Related]
9. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells. Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295 [TBL] [Abstract][Full Text] [Related]
10. Antileukemia activity of a natural killer cell line against human leukemias. Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753 [TBL] [Abstract][Full Text] [Related]
11. Human tumor antigen-specific T lymphocytes and interleukin-2-activated natural killer cells: comparisons of antitumor effects in vitro and in vivo. Whiteside TL; Sung MW; Nagashima S; Chikamatsu K; Okada K; Vujanovic NL Clin Cancer Res; 1998 May; 4(5):1135-45. PubMed ID: 9607570 [TBL] [Abstract][Full Text] [Related]
12. Human interleukin-2-activated adherent natural killer cells recognize a conserved antigen found on tumor cells and protozoan parasites. Weisman Z; Evans DL; Jaso-Friedmann L Nat Immun; 1996-1997; 15(6):269-84. PubMed ID: 9523279 [TBL] [Abstract][Full Text] [Related]
13. Activated T cells inhibit NK cell-mediated tumour rejection. Wang XJ; Hu J; Yuan J; Peng YM; Gui L; He WF; Tan J; Luo GX; Wu J Scand J Immunol; 2009 Apr; 69(4):337-41. PubMed ID: 19284498 [TBL] [Abstract][Full Text] [Related]
14. Microvessel origin and distribution in pulmonary metastases of B16 melanoma: implication for adoptive immunotherapy. Nannmark U; Johansson BR; Bryant JL; Unger ML; Hokland ME; Goldfarb RH; Basse PH Cancer Res; 1995 Oct; 55(20):4627-32. PubMed ID: 7553640 [TBL] [Abstract][Full Text] [Related]
15. Accumulation of adoptively transferred A-NK cells in murine metastases: kinetics and role of interleukin-2. Basse PH; Goldfarb RH; Herberman RB; Hokland ME In Vivo; 1994; 8(1):17-24. PubMed ID: 8054506 [TBL] [Abstract][Full Text] [Related]
16. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma. Muralikrishna K; Varalakshmi C; Khar A Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244 [TBL] [Abstract][Full Text] [Related]
18. Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery. Da Costa ML; Redmond HP; Bouchier-Hayes DJ J Surg Res; 2001 Dec; 101(2):111-9. PubMed ID: 11735264 [TBL] [Abstract][Full Text] [Related]
19. Morphological studies of effector cell-microvessel interactions in adoptive immunotherapy in tumor-bearing animals. Nannmark U; Basse P; Johansson BR; Kuppen P; Kjergaard J; Hokland M Nat Immun; 1996-1997; 15(2-3):78-86. PubMed ID: 9162266 [TBL] [Abstract][Full Text] [Related]